sulpiride has been researched along with Amphetamine-Related Disorders in 6 studies
Sulpiride: A dopamine D2-receptor antagonist. It has been used therapeutically as an antidepressant, antipsychotic, and as a digestive aid. (From Merck Index, 11th ed)
sulpiride : A member of the class of benzamides obtained from formal condensation between the carboxy group of 2-methoxy-5-sulfamoylbenzoic acid and the primary amino group of (1-ethylpyrrolidin-2-yl)methylamine.
Amphetamine-Related Disorders: Disorders related or resulting from use of amphetamines.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To measure behavioral and brain functional markers of drug-related attentional bias in stimulant-dependent individuals studied repeatedly after short-term dosing with dopamine D(2)/D(3) receptor antagonist and agonist challenges." | 1.36 | Influence of compulsivity of drug abuse on dopaminergic modulation of attentional bias in stimulant dependence. ( Abbott, S; Barnes, A; Bullmore, ET; Craig, KJ; Ersche, KD; Merlo-Pich, EV; Müller, U; Ooi, C; Robbins, TW; Sahakian, BJ; Shabbir, SS; Suckling, J, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hiranita, T | 1 |
| Yamamoto, T | 1 |
| Nawata, Y | 1 |
| Ersche, KD | 2 |
| Bullmore, ET | 2 |
| Craig, KJ | 2 |
| Shabbir, SS | 2 |
| Abbott, S | 2 |
| Müller, U | 2 |
| Ooi, C | 2 |
| Suckling, J | 2 |
| Barnes, A | 1 |
| Sahakian, BJ | 2 |
| Merlo-Pich, EV | 2 |
| Robbins, TW | 2 |
| Roiser, JP | 1 |
| Clark, L | 1 |
| Fineberg, NA | 1 |
| Suzuki, T | 1 |
| Mizuo, K | 1 |
| Nakazawa, H | 1 |
| Funae, Y | 1 |
| Fushiki, S | 1 |
| Fukushima, S | 1 |
| Shirai, T | 1 |
| Narita, M | 1 |
| Kusayama, T | 1 |
| Watanabe, S | 1 |
| Cancela, LM | 1 |
| Basso, AM | 1 |
| Martijena, ID | 1 |
| Capriles, NR | 1 |
| Molina, VA | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Dopamine D2/3- and μ-opioid Receptor Antagonists Reduce Cue-induced Reward Responding and Reward Impulsivity in Healthy Volunteers[NCT02557984] | 121 participants (Actual) | Interventional | 2014-02-28 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for sulpiride and Amphetamine-Related Disorders
| Article | Year |
|---|---|
Response perseveration in stimulant dependence is associated with striatal dysfunction and can be ameliorated by a D(2/3) receptor agonist.
Topics: Adult; Amisulpride; Amphetamine-Related Disorders; Benzothiazoles; Brain Mapping; Cocaine-Related Di | 2011 |
5 other studies available for sulpiride and Amphetamine-Related Disorders
| Article | Year |
|---|---|
A tryptamine-derived catecholaminergic enhancer, (-)-1-(benzofuran-2-yl)-2-propylaminopentane [(-)-BPAP], attenuates reinstatement of methamphetamine-seeking behavior in rats.
Topics: Adrenergic Agents; Amisulpride; Amphetamine-Related Disorders; Animals; Benzazepines; Benzofurans; C | 2010 |
Influence of compulsivity of drug abuse on dopaminergic modulation of attentional bias in stimulant dependence.
Topics: Adult; Amisulpride; Amphetamine-Related Disorders; Attention; Benzothiazoles; Bias; Cerebellar Corte | 2010 |
Prenatal and neonatal exposure to bisphenol-A enhances the central dopamine D1 receptor-mediated action in mice: enhancement of the methamphetamine-induced abuse state.
Topics: Air Pollutants, Occupational; Amphetamine-Related Disorders; Animals; Animals, Newborn; Behavior, An | 2003 |
Reinforcing effects of methamphetamine in planarians.
Topics: Amphetamine-Related Disorders; Animals; Behavior, Animal; Benzazepines; Brain; Conditioning, Psychol | 2000 |
A dopaminergic mechanism is involved in the 'anxiogenic-like' response induced by chronic amphetamine treatment: a behavioral and neurochemical study.
Topics: Amphetamine; Amphetamine-Related Disorders; Animals; Anxiety; Behavior, Animal; Benzazepines; Brain; | 2001 |